← All organizations
Highest phase reached
Phase 2
First clinical trial
Apr 1, 2021Last known activity
Oct 30, 2024
Acquired by Roche on Dec 4, 2023
Timeline
2000s
- Jun 1, 2008
Carmot Therapeutics, Inc.— Founded
2020s
- Dec 4, 2023
Roche— Acquired By
Drugs by trial phase (4 distinct, 8 trials)
Phase 1 (2 own, 0 via acquisition)
Recent trials (15)
- NCT06628362Lead sponsorPhase 2Oct 30, 2024
- NCT06525935Lead sponsorPhase 2Aug 16, 2024
- NCT06062069Lead sponsorPhase 2Oct 19, 2023
- NCT05814107CollaboratorPhase 1May 9, 2023
- NCT05814107Lead sponsorPhase 1May 9, 2023
- NCT05814107Study directorPhase 1May 9, 2023
- NCT05794581Lead sponsorPhase 1Mar 21, 2023
- NCT05794581Study directorPhase 1Mar 21, 2023
- NCT05110846Lead sponsorPhase 2Dec 8, 2021
- NCT05110846Study directorPhase 2Dec 8, 2021
- NCT04973111Study directorPhase 1Jul 12, 2021
- NCT04973111Lead sponsorPhase 1Jul 12, 2021
- NCT04838405CollaboratorPhase 1Apr 1, 2021
- NCT04838405Study directorPhase 1Apr 1, 2021
- NCT04838405Lead sponsorPhase 1Apr 1, 2021
Details
- Founded
- SAN FRANCISCO, CA, US Jun 1, 2008
- Last known activity
- Oct 30, 2024